Healthcare -
Biotechnology - NASDAQ - US
$ 11.535
-1.49 %
$ 467 M
Market Cap
-2.21
P/E
KROS - OTHER CURRENT LIABILITIES
Other Current Liabilities KROS - Keros Therapeutics, Inc.
17.9 M
LAST VALUE
67.76%
2 YEAR CAGR
103.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR